TR200101209T2 - Teneffüs yoluyla uygulanan ilaç parçacıklarının süspansiyonlarının hazırlanması için bir işlem - Google Patents

Teneffüs yoluyla uygulanan ilaç parçacıklarının süspansiyonlarının hazırlanması için bir işlem

Info

Publication number
TR200101209T2
TR200101209T2 TR2001/01209T TR200101209T TR200101209T2 TR 200101209 T2 TR200101209 T2 TR 200101209T2 TR 2001/01209 T TR2001/01209 T TR 2001/01209T TR 200101209 T TR200101209 T TR 200101209T TR 200101209 T2 TR200101209 T2 TR 200101209T2
Authority
TR
Turkey
Prior art keywords
preparation
suspensions
inhalation
drug particles
directed
Prior art date
Application number
TR2001/01209T
Other languages
English (en)
Inventor
Bernini Eva
Malvolti Chiara
Garzia Raffaella
Brambilla Gaetano
Chiesi Paolo
Original Assignee
Chiesi Farmaceutici S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiesi Farmaceutici S.P.A. filed Critical Chiesi Farmaceutici S.P.A.
Publication of TR200101209T2 publication Critical patent/TR200101209T2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/906—Drug delivery
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S977/00—Nanotechnology
    • Y10S977/902—Specified use of nanostructure
    • Y10S977/904—Specified use of nanostructure for medical, immunological, body treatment, or diagnosis
    • Y10S977/926—Topical chemical, e.g. cosmetic or sunscreen

Abstract

Bulus, teneffüs yoluyla uygulanmak üzere ilaç parçaciklarinin süspansiyonlarinin hazirlanmasi için bir isleme yönelik olup, bahsedilen islem optimize parçacik boyutu ve tasiyici içinde homojen olarak dagilma dagilimi olan parçaciklari saglar. Steril süspansiyonlarin hazirlanmasi için de uygun olan bu islem, formülasyonun yüksek güçlü türbin ile donatilmis bir turbo-emülsiflestirici içinde homojenlestirme ve mikronlastirma adimini ve opsiyonel olarak ardindan bir yüksek basinçli homojenlestirici içinde bir islem adimini içerir. Bulusun diger bir amaci ise mikronlastirilmis steril beklometason dipropionatin gama isimasi ile hazirlanmasi için olan bir isleme de yöneliktir.
TR2001/01209T 1998-11-03 1999-10-28 Teneffüs yoluyla uygulanan ilaç parçacıklarının süspansiyonlarının hazırlanması için bir işlem TR200101209T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI002364A IT1303692B1 (it) 1998-11-03 1998-11-03 Procedimento per la preparazione di sospensioni di particelle difarmaci da somministrare per inalazione.

Publications (1)

Publication Number Publication Date
TR200101209T2 true TR200101209T2 (tr) 2001-09-21

Family

ID=11380994

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/01209T TR200101209T2 (tr) 1998-11-03 1999-10-28 Teneffüs yoluyla uygulanan ilaç parçacıklarının süspansiyonlarının hazırlanması için bir işlem

Country Status (26)

Country Link
US (1) US6464958B1 (tr)
EP (2) EP1126823B1 (tr)
JP (1) JP2002528484A (tr)
KR (1) KR100783096B1 (tr)
CN (1) CN1158997C (tr)
AT (1) ATE352288T1 (tr)
AU (1) AU762367B2 (tr)
BR (2) BRPI9917701B1 (tr)
CA (2) CA2349268C (tr)
CY (2) CY1107659T1 (tr)
CZ (2) CZ2007211A3 (tr)
DE (1) DE69935002T2 (tr)
DK (2) DK1126823T3 (tr)
EA (1) EA003228B1 (tr)
ES (1) ES2281197T3 (tr)
HU (2) HU230121B1 (tr)
IT (1) IT1303692B1 (tr)
NO (1) NO20012175L (tr)
NZ (1) NZ511305A (tr)
PL (1) PL195908B1 (tr)
PT (1) PT1126823E (tr)
SI (1) SI1126823T1 (tr)
SK (2) SK288316B6 (tr)
TR (1) TR200101209T2 (tr)
WO (1) WO2000025746A2 (tr)
ZA (1) ZA200103526B (tr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69633222T2 (de) * 1995-02-24 2005-09-08 Elan Pharma International Ltd. Nanopartikel-dispersionen enthaltende aerosole
CZ303495B6 (cs) 1998-11-02 2012-10-24 Elan Pharma International Limited Mnohocásticový modifikovane uvolnující prostredek a jeho použití, pevná orální dávkovací forma
AUPQ573300A0 (en) * 2000-02-21 2000-03-16 Australian Nuclear Science & Technology Organisation Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use
NZ523693A (en) * 2000-07-10 2004-08-27 Chiron Corp Macrolide formulations for inhalation and methods of treatment of endobronchial infections
SG98420A1 (en) * 2000-07-13 2003-09-19 Purzer Pharmaceutical Co Ltd Method for transferring one or more active ingredients between different phase carriers
US6667344B2 (en) 2001-04-17 2003-12-23 Dey, L.P. Bronchodilating compositions and methods
US20030091513A1 (en) * 2001-10-03 2003-05-15 Mohsen Nahed M. Method to generate water soluble or nonwater soluble in nanoparticulates directly in suspension or dispersion media
US20030129242A1 (en) * 2002-01-04 2003-07-10 Bosch H. William Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
EP1476201B1 (en) 2002-02-19 2008-12-24 Resolution Chemicals Limited Solvent-based sterilisation of steroids
ITMI20020808A1 (it) * 2002-04-17 2003-10-17 Chiesi Farma Spa Procedimento per la preparazione di una sospensione sterile di particelle di beclometasone dipropionato da somministrare per inalazione
EP1556091A1 (en) * 2002-10-04 2005-07-27 Elan Pharma International Limited Gamma irradiation of solid nanoparticulate active agents
ITMI20022674A1 (it) * 2002-12-18 2004-06-19 Chiesi Farma Spa Procedimento per la preparazione di formulazioni sterili a base di principi attivi farmaceutici cristallini micronizzati da somministrare come sospensioni acquose per inalazione.
US20040208833A1 (en) * 2003-02-04 2004-10-21 Elan Pharma International Ltd. Novel fluticasone formulations
EP1594471B1 (en) * 2003-02-20 2009-03-25 Constant Research & Development Limited Process for manufacturing a dexamethasone-containing formulation for oral administration
EP1454636A1 (en) * 2003-03-04 2004-09-08 Dompé S.P.A. Sterilization of glucocorticoid drug particles for pulmonary delivery
US9808471B2 (en) * 2003-04-16 2017-11-07 Mylan Specialty Lp Nasal pharmaceutical formulations and methods of using the same
US8912174B2 (en) * 2003-04-16 2014-12-16 Mylan Pharmaceuticals Inc. Formulations and methods for treating rhinosinusitis
US7811606B2 (en) * 2003-04-16 2010-10-12 Dey, L.P. Nasal pharmaceutical formulations and methods of using the same
WO2004105809A1 (en) * 2003-05-22 2004-12-09 Elan Pharma International Ltd. Sterilization of dispersions of nanoparticulate active agents with gamma radiation
TWI359675B (en) 2003-07-10 2012-03-11 Dey L P Bronchodilating β-agonist compositions
GB0319500D0 (en) * 2003-08-19 2003-09-17 Resolution Chemicals Ltd Particle-size reduction apparatus,and use thereof
ITMI20032054A1 (it) 2003-10-22 2005-04-23 Monteres S R L Processo per la preparazione di sospensioni farmaceutiche da inalare.
MXPA06005604A (es) * 2003-11-18 2007-01-30 Yansong Shan Dispositivo de inhalacion saludable yagradable.
PE20050941A1 (es) 2003-12-16 2005-11-08 Nycomed Gmbh Suspensiones acuosas de ciclesonida para nebulizacion
ATE497787T1 (de) * 2004-03-12 2011-02-15 Cipla Ltd Sterilisationsprozess für steroide
WO2005089718A2 (en) 2004-03-23 2005-09-29 Novartis Ag Pharmaceutical compositions
GB0406515D0 (en) * 2004-03-23 2004-04-28 Novartis Ag Organic compounds
ITMI20040795A1 (it) * 2004-04-23 2004-07-23 Eratech S R L Composizione farmaceutica solida secca suo processo di preparazione e sospensione acquosa stabile ottenuta dalla stessa
GB0410995D0 (en) * 2004-05-17 2004-06-23 Norton Healthcare Ltd Heat sterilization of glucocorticosteroids
EA200701065A1 (ru) * 2004-11-16 2007-12-28 Элан Фарма Интернэшнл Лтд. Инъецируемые составы, содержащие нанодисперсный оланзапин
GB0425266D0 (en) 2004-11-16 2004-12-15 Norton Healthcare Ltd Pharmaceutical manufacturing process
GB0427568D0 (en) 2004-12-16 2005-01-19 Resolution Chemicals Ltd Particle-size reduction apparatus, and the use thereof
ES2388287T3 (es) 2005-01-20 2012-10-11 Eratech S.R.L. Procedimiento para la preparación de suspensiones concentradas de fármacos y kit correspondiente
EP1968547A1 (en) * 2005-11-29 2008-09-17 Farmabios S.p.A. Process for the preparation of micronised sterile steroids
BRPI0714173A2 (pt) * 2006-07-12 2012-12-25 Elan Pharma Int Ltd composiÇço nanoparticulada estÁvel,mÉtodos para preparar a composiÇço, para prevenir e/ou tratar estados de doenÇas, sintomas, sÍndromes e condiÇÕes do sistema nervoso central, para melhorar ou manter a biodisponibilidade de modafinil, e para tratar distérbio com base neurolàgica, composiÇço farmacÊutica, e forma de dosagem
CA2707594C (en) * 2007-12-13 2015-08-18 Novartis Ag Process for preparing particulates of crystalline drug substance
AU2010252354B2 (en) * 2009-05-25 2016-05-19 Chiesi Farmaceutici S.P.A. A therapeutic combination comprising a pulmonary surfactant and a steroid
HUE030016T2 (en) 2011-05-03 2017-04-28 Chiesi Farm Spa An improved suspension beclomethasone dipropionate formulation for inhalation administration
DK2704687T3 (en) 2011-05-04 2015-10-05 Chiesi Farma Spa Topical formulation having a corticosteroid as an active ingredient
CN104739811A (zh) * 2015-02-27 2015-07-01 上海臣邦医药科技有限公司 一种糖皮质激素雾化吸入混悬液及其制备方法
TWI773641B (zh) * 2015-05-08 2022-08-11 日商活效製藥股份有限公司 含有糖皮質類固醇（ｇｌｕｃｏｃｏｒｔｉｃｏｉｄｓ）之奈米微粒子之水性懸浮液劑
WO2023136787A1 (en) * 2022-01-17 2023-07-20 Arven Ilac Sanayi Ve Ticaret Anonim Sirketi Process for the preparation of a sterile, homogeneous suspension for inhalation by nebulization

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69002718T2 (de) * 1989-09-08 1993-12-23 Glaxo Group Ltd Medikamente.
US5126123A (en) * 1990-06-28 1992-06-30 Glaxo, Inc. Aerosol drug formulations
JPH0486921A (ja) * 1990-07-31 1992-03-19 Omron Corp 近似推論のための知識ベース形成方法および装置
US5046326A (en) 1990-10-24 1991-09-10 Thermo King Corporation Transport refrigeration system
IT1243911B (it) * 1990-11-19 1994-06-28 Zambon Spa Composizioni per la terapia mucolitica
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
IL101387A (en) * 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
UY24147A1 (es) * 1995-01-20 1996-02-02 Gruenenthal Chemie Procedimiento y dispositivo para preparar composiciones dispersables por aspersion de aerosoles
US6135628A (en) * 1995-10-13 2000-10-24 Boehringer Ingelheim Pharmceuticals, Inc. Method and apparatus for homogenizing aerosol formulations
IT1286496B1 (it) 1996-11-20 1998-07-15 Leetrim Ltd Dublin Composizione farmaceutica orale ad attivita' antipiretica,analgesica ed antiinfiammatoria
SE9704186D0 (sv) 1997-11-14 1997-11-14 Astra Ab New composition of matter

Also Published As

Publication number Publication date
EP1832279A3 (en) 2008-03-05
WO2000025746A2 (en) 2000-05-11
CY1107659T1 (el) 2013-04-18
EP1126823A2 (en) 2001-08-29
IT1303692B1 (it) 2001-02-23
CZ20011541A3 (cs) 2001-09-12
ITMI982364A1 (it) 2000-05-03
EP1832279A2 (en) 2007-09-12
PT1126823E (pt) 2007-04-30
CA2349268C (en) 2009-03-31
DE69935002T2 (de) 2007-07-19
SK285487B6 (sk) 2007-02-01
CZ300650B6 (cs) 2009-07-08
HUP0104230A3 (en) 2006-07-28
KR100783096B1 (ko) 2007-12-07
KR20010075656A (ko) 2001-08-09
NO20012175D0 (no) 2001-05-02
BRPI9915251B1 (pt) 2015-09-01
BRPI9915251B8 (pt) 2021-05-25
CA2614633C (en) 2010-12-21
EA003228B1 (ru) 2003-02-27
WO2000025746A3 (en) 2000-10-26
US6464958B1 (en) 2002-10-15
HUP0104230A2 (hu) 2002-03-28
PL195908B1 (pl) 2007-11-30
ES2281197T3 (es) 2007-09-16
CZ306939B6 (cs) 2017-09-27
HU226734B1 (en) 2009-08-28
HU230121B1 (hu) 2015-08-28
EP1832279B1 (en) 2015-07-01
CN1335766A (zh) 2002-02-13
CN1158997C (zh) 2004-07-28
ZA200103526B (en) 2002-06-03
JP2002528484A (ja) 2002-09-03
ATE352288T1 (de) 2007-02-15
PL347908A1 (en) 2002-04-22
SK288316B6 (sk) 2015-11-03
DK1832279T3 (en) 2015-10-05
EA200100397A1 (ru) 2001-10-22
NO20012175L (no) 2001-07-02
SK5932001A3 (en) 2001-11-06
CZ2007211A3 (cs) 2017-09-27
BRPI9917701B1 (pt) 2016-07-19
NZ511305A (en) 2003-07-25
DE69935002D1 (de) 2007-03-15
DK1126823T3 (da) 2007-05-21
AU762367B2 (en) 2003-06-26
CA2614633A1 (en) 2000-05-11
HU0700446D0 (en) 2007-08-28
EP1126823B1 (en) 2007-01-24
AU1266600A (en) 2000-05-22
SI1126823T1 (sl) 2007-04-30
CA2349268A1 (en) 2000-05-11
CY1116943T1 (el) 2017-04-05
BR9915251A (pt) 2001-10-30

Similar Documents

Publication Publication Date Title
TR200101209T2 (tr) Teneffüs yoluyla uygulanan ilaç parçacıklarının süspansiyonlarının hazırlanması için bir işlem
ES2103946T3 (es) Excipiente farmaceutico.
CA1330295C (en) Treatments employing vasoconstrictive substances in combination with cytotoxic agents for introduction into cellular lesion areas
IL144597A0 (en) Hydrogel particle formulations
ATE387430T1 (de) Verbindungen und zusammensetzungen zur abgabe aktiver wirkstoffe
EP2246049A3 (en) Pharmaceutical composition and dosage forms for administration of hydrophobic drugs
CA2481520A1 (en) Process for preparation of a sterile suspension of corticosteroid particles for administration by inhalation
Chleboun et al. Skeletal cryptococcosis
EP0872231B1 (en) Pharmaceutical compositions comprising lactobacilli suitable for trans-mucosal administration
CN102018670B (zh) 一种抗癌制剂
SE8600496D0 (sv) Pharmaceutical 9,10-dihydro ergot alkaloid containing compositions
US20130084329A1 (en) Compositions for external application, containing adenosylcobalamin for improvement of skin diseases
Coombes et al. PATIENTS AND METHODS Patients Forty-one patients with advanced breast cancer and measurable metastatic disease were treated with trilo-stane. All patients were fully assessed by conventional
ECSP961835A (es) Nuevo procedimiento